Cartesian Therapeutics Inc's Customers Performance

Name: Cartesian Therapeutics Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

RNAC

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


RNAC's Source of Revenues		• List of RNAC Customers

for the same period Cartesian Therapeutics Inc

• List of RNAC Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Cartesian Therapeutics Inc's Comment on Sales, Marketing and Customers

News about Cartesian Therapeutics Inc Contracts

Breaking New Ground Cartesian Therapeutics Advances Multiple Innovative Therapies for Myasthenia Gravis and Beyond

In the realm of biotechnology and therapeutics, innovation continually shapes the landscape of treatment options available for complex and often debilitating conditions. Cartesian Therapeutics is making remarkable strides on this front, particularly in their ongoing development of therapies aimed at Myasthenia Gravis (MG) and novel approaches to CAR-T cell therapy. The company s recent activities reflect both its commitment to advancing therapeutic modalities and its strategic engagement with regulatory bodies.At the forefront of their initiatives is the recent presentation of results from the Phase 2b clinical trial of Descartes-08, a targeted mRNA therapy specifically designed for patients with Myasthenia ...

Breaking New Ground in Pediatric Autoimmune Therapy Cartesian Therapeutics’ Descartes-08 Garners FDA Rar...

Cartesian Therapeutics, a pioneering cellular therapeutics company, has made significant strides in the field of pediatric medicine. Recently, the company announced that it has received the U.S. Food and Drug Administration (FDA) Rare Pediatric Disease Designation (RPDD) for its drug candidate Descartes-08, aimed at treating Juvenile Dermatomyositis (JDM). Additionally, the Investigational New Drug (IND) application filing for a Phase 2 pediatric basket study is on track to be completed by the end of the year. This announcement marks a promising advancement in the quest to combat rare pediatric diseases and provides hope for young patients suffering from this debilitating condition. Juvenile Dermatomyositis ...

Cartesian Therapeutics Elevates Cell Therapy Manufacturing in Frederick, Maryland

Cartesian Therapeutics solidifies foothold in cell therapy field with cutting-edge manufacturing facilityFrederick, Maryland - Cartesian Therapeutics, a leading biotechnology company known for its mRNA cell therapies, has recently unveiled its new state-of-the-art corporate headquarters and cGMP manufacturing facility. This establishment aims to bolster the company s capability to produce clinical and commercial supplies of mRNA cell therapies specifically designed to combat autoimmune diseases.The strategic decision to set up headquarters in Frederick, Maryland signifies Cartesian Therapeutics commitment to growth and development within the rapidly evolving cell therapy industry. The new facility is poised...

RNAC's Stock Performance relative to it's Customers

RNAC's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Cartesian Therapeutics Inc	267.25	1.78	-151.77	75
SUBTOTAL	0.00	0.00	0.00	-

Sources: Cartesian Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Cartesian Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Cartesian Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.